Evidence map›Paper›PMID 37258907›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

Unbiased, High-Throughput Identification of T Cell Epitopes by ELISPOT.

Paul V Lehmann, Diana R Roen, Alexander A Lehmann

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Paul V LehmannResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH, USA. paul.lehmann@immunospot.com.
Diana R RoenResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH, USA.
Alexander A LehmannResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH, USA.
Shaker Heights Public Library · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent systematic immune monitoring efforts suggest that, in humans, epitope recognition by T cells is far more complex than has been assumed based on minimalistic murine models. The increased complexity is due to the higher number of HLA loci in humans, the typical heterozygosity for these loci in the outbred population, and the high number of peptides that each HLA restriction element can bind with an affinity that suffices for antigen presentation. The sizable array of potential epitopes on any given antigen is due to each individual's unique HLA allele makeup. Of this individualized potential epitope space, chance events occurring in the course of the T cell response determine which epitopes induce dominant T cell expansions. Establishing the actually-engaged T cell repertoire in each human subject, including the individualized peptides targeted, therefore requires the systematic testing of all peptides that constitute the potential epitope space in that person. The goal of comprehensive, high-throughput epitope mapping can be readily established by the methods described in this chapter.

Indexed as

CD8-Positive T-LymphocytesEpitopes, T-LymphocyteAnimalsEnzyme-Linked Immunospot AssayEpitope MappingHumansMicePeptidesEpitopes, T-LymphocytePeptidesCD4 T cellCD8 T cellElispotEpitope predictionFluorospotImmune monitoringT cell determinant

Identifiers

PMID37258907
OpenAlexW4378801459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.